IL-5 antagonist (Chiba University)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameIL-5 antagonist (Chiba University)
Drug Alias NameIL-5 antagonist (Ishihara Sangyo Kaisha)SH-2251
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-5 receptors inhibitors
TargetsInterleukin-5 receptors
Therapy Area/IndicationsInflammationHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIshihara Sangyo Kaisha
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIshihara Sangyo KaishaChiba University
Active IndicationsN/A
Inactive IndicationsInflammationHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A